|
|
|
Volumn 57, Issue 4, 2002, Pages 215-216
|
|
Time trends in the HERS secondary prevention trial: much ado about nothing?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
MEDROXYPROGESTERONE ACETATE;
PROGESTERONE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
ESTROGEN THERAPY;
FEMALE;
HEART INFARCTION;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
SUDDEN DEATH;
TREATMENT OUTCOME;
ADULT;
AGED;
DEATH, SUDDEN, CARDIAC;
DRUG COMBINATIONS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS, CONJUGATED (USP);
FEMALE;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MYOCARDIAL INFARCTION;
PROGESTERONE CONGENERS;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 0036730515
PISSN: 00988421
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
